Literature DB >> 23430927

Expanding the Spectrum of PMM2-CDG Phenotype.

Sandrine Vuillaumier-Barrot1, Bertrand Isidor, Thierry Dupré, Christiane Le Bizec, Albert David, Nathalie Seta.   

Abstract

Congenital Disorders of Glycosylation (CDG) are a group of recently described inborn errors of metabolism affecting glycosylation. CDG are disorders that have been reported with a great variability in the clinical presentation, especially for the most common PMM2-CDG. The classical form is neurologic but severe forms with multisystem disorders and hydrops fetalis have been described. Here, we extend on the opposite end the clinical spectrum to an asymptomatic PMM2-CDG case. The case was the father of a child who died of neonatal galactosemia few days after birth. He presented without any clinical or biological signs, except a typical CDG 1 pattern in Western blot of glycoproteins associated with a deficient phosphomannomutase activity in blood leukocytes and compound heterozygosity in PMM2 gene. The sister of the father, who was also affected by PMM deficiency, presented with infertility and premature ovarian failure. Finally, the absence of any abnormal clinical or biological signs as for the case completes the clinical spectrum of PMM2-CDG at its extreme end, at the opposite of the supposed total lethality of the R141H homozygous status.

Entities:  

Year:  2011        PMID: 23430927      PMCID: PMC3509917          DOI: 10.1007/8904_2011_114

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  6 in total

1.  Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).

Authors:  E Schollen; S Kjaergaard; E Legius; M Schwartz; G Matthijs
Journal:  Eur J Hum Genet       Date:  2000-05       Impact factor: 4.246

2.  Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).

Authors:  G Matthijs; E Schollen; C Bjursell; A Erlandson; H Freeze; F Imtiaz; S Kjaergaard; T Martinsson; M Schwartz; N Seta; S Vuillaumier-Barrot; V Westphal; B Winchester
Journal:  Hum Mutat       Date:  2000-11       Impact factor: 4.878

Review 3.  Should PMM2-deficiency (CDG Ia) be searched in every case of unexplained hydrops fetalis?

Authors:  Nadia Léticée; Bettina Bessières-Grattagliano; Thierry Dupré; Sandrine Vuillaumier-Barrot; Pascale de Lonlay; Ferechté Razavi; Nadia El Khartoufi; Yves Ville; Michel Vekemans; Raymonde Bouvier; Nathalie Seta; Tania Attié-Bitach
Journal:  Mol Genet Metab       Date:  2010-06-22       Impact factor: 4.797

Review 4.  The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).

Authors:  Stephanie Grünewald
Journal:  Biochim Biophys Acta       Date:  2009-01-14

Review 5.  Congenital disorders of glycosylation: a booming chapter of pediatrics.

Authors:  Jaak Jaeken; Hubert Carchon
Journal:  Curr Opin Pediatr       Date:  2004-08       Impact factor: 2.856

6.  Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome.

Authors:  B Kristiansson; H Stibler; L Wide
Journal:  Acta Paediatr       Date:  1995-06       Impact factor: 2.299

  6 in total
  7 in total

1.  UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase is indispensable for oogenesis, oocyte-to-embryo transition, and larval development of the nematode Caenorhabditis elegans.

Authors:  Nanako Kanaki; Ayako Matsuda; Katsufumi Dejima; Daisuke Murata; Kazuko H Nomura; Takashi Ohkura; Keiko Gengyo-Ando; Sawako Yoshina; Shohei Mitani; Kazuya Nomura
Journal:  Glycobiology       Date:  2019-02-01       Impact factor: 4.313

2.  Etiology of primary ovarian insufficiency in a series young girls presenting at a pediatric endocrinology center.

Authors:  Raja Brauner; Sophie Pierrepont; Joelle Bignon-Topalovic; Ken McElreavey; Anu Bashamboo
Journal:  Eur J Pediatr       Date:  2014-11-27       Impact factor: 3.183

3.  Causal and Candidate Gene Variants in a Large Cohort of Women With Primary Ovarian Insufficiency.

Authors:  Bushra Gorsi; Edgar Hernandez; Marvin Barry Moore; Mika Moriwaki; Clement Y Chow; Emily Coelho; Elaine Taylor; Claire Lu; Amanda Walker; Philippe Touraine; Lawrence M Nelson; Amber R Cooper; Elaine R Mardis; Aleksander Rajkovic; Mark Yandell; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

Review 4.  Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation.

Authors:  Anna Čechová; Ruqaiah Altassan; Delphine Borgel; Arnaud Bruneel; Joana Correia; Muriel Girard; Annie Harroche; Beata Kiec-Wilk; Klaus Mohnike; Tiffany Pascreau; Łukasz Pawliński; Silvia Radenkovic; Sandrine Vuillaumier-Barrot; Luis Aldamiz-Echevarria; Maria Luz Couce; Esmeralda G Martins; Dulce Quelhas; Eva Morava; Pascale de Lonlay; Peter Witters; Tomáš Honzík
Journal:  J Inherit Metab Dis       Date:  2020-04-21       Impact factor: 4.982

5.  Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?

Authors:  Peter Witters; Tomas Honzik; Eric Bauchart; Ruqaiah Altassan; Tiffany Pascreau; Arnaud Bruneel; Sandrine Vuillaumier; Nathalie Seta; Delphine Borgel; Gert Matthijs; Jaak Jaeken; Wouter Meersseman; David Cassiman; Lonlay Pascale de; Eva Morava
Journal:  Genet Med       Date:  2018-10-08       Impact factor: 8.822

6.  Genotype-Phenotype Correlations in PMM2-CDG.

Authors:  Laurien Vaes; Daisy Rymen; David Cassiman; Anna Ligezka; Nele Vanhoutvin; Dulce Quelhas; Eva Morava; Peter Witters
Journal:  Genes (Basel)       Date:  2021-10-21       Impact factor: 4.096

7.  A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report.

Authors:  A Klein; F Foulquier; E Lebredonchel; A Riquet; D Neut; F Broly; G Matthijs
Journal:  Ital J Pediatr       Date:  2022-10-11       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.